105 related articles for article (PubMed ID: 1919444)
21. A clinical exploratory study with itolizumab, an anti-CD6 monoclonal antibody, in patients with rheumatoid arthritis.
Rodriguez PC; Torres-Moya R; Reyes G; Molinero C; Prada D; Lopez AM; Hernandez IM; Hernandez MV; Martinez JP; Hernandez X; Casaco A; Ramos M; Avila Y; Barrese Y; Montero E; Hernandez P
Results Immunol; 2012; 2():204-11. PubMed ID: 24371585
[TBL] [Abstract][Full Text] [Related]
22. Fine mapping and functional analysis of the multiple sclerosis risk gene CD6.
Swaminathan B; Cuapio A; Alloza I; Matesanz F; Alcina A; García-Barcina M; Fedetz M; Fernández O; Lucas M; Orpez T; Pinto-Medel MJ; Otaegui D; Olascoaga J; Urcelay E; Ortiz MA; Arroyo R; Oksenberg JR; Antigüedad A; Tolosa E; Vandenbroeck K
PLoS One; 2013; 8(4):e62376. PubMed ID: 23638056
[TBL] [Abstract][Full Text] [Related]
23. CD6 attenuates early and late signaling events, setting thresholds for T-cell activation.
Oliveira MI; Gonçalves CM; Pinto M; Fabre S; Santos AM; Lee SF; Castro MA; Nunes RJ; Barbosa RR; Parnes JR; Yu C; Davis SJ; Moreira A; Bismuth G; Carmo AM
Eur J Immunol; 2012 Jan; 42(1):195-205. PubMed ID: 21956609
[TBL] [Abstract][Full Text] [Related]
24. Anti-γδ TCR antibody-expanded γδ T cells: a better choice for the adoptive immunotherapy of lymphoid malignancies.
Zhou J; Kang N; Cui L; Ba D; He W
Cell Mol Immunol; 2012 Jan; 9(1):34-44. PubMed ID: 21666706
[TBL] [Abstract][Full Text] [Related]
25. A conserved enhancer element differentially regulates developmental expression of CD5 in B and T cells.
Berland R; Fiering S; Wortis HH
J Immunol; 2010 Dec; 185(12):7537-43. PubMed ID: 21076064
[TBL] [Abstract][Full Text] [Related]
26. CD6 synergistic co-stimulation promoting proinflammatory response is modulated without interfering with the activated leucocyte cell adhesion molecule interaction.
Nair P; Melarkode R; Rajkumar D; Montero E
Clin Exp Immunol; 2010 Oct; 162(1):116-30. PubMed ID: 20726988
[TBL] [Abstract][Full Text] [Related]
27. Cloning and characterization of a fourth human lysyl oxidase isoenzyme.
Mäki JM; Kivirikko KI
Biochem J; 2001 Apr; 355(Pt 2):381-7. PubMed ID: 11284725
[TBL] [Abstract][Full Text] [Related]
28. Dynamic expression of multiple scavenger receptor cysteine-rich genes in coelomocytes of the purple sea urchin.
Pancer Z
Proc Natl Acad Sci U S A; 2000 Nov; 97(24):13156-61. PubMed ID: 11069281
[TBL] [Abstract][Full Text] [Related]
29. Molecular cloning, genomic organization and cell-binding characteristics of mouse Spalpha.
Gebe JA; Llewellyn M; Hoggatt H; Aruffo A
Immunology; 2000 Jan; 99(1):78-86. PubMed ID: 10651944
[TBL] [Abstract][Full Text] [Related]
30. Differential effect on TCR:CD3 stimulation of a 90-kD glycoprotein (gp90/Mac-2BP), a member of the scavenger receptor cysteine-rich domain protein family.
Silvestri B; Calderazzo F; Coppola V; Rosato A; Iacobelli S; Natoli C; Ullrich A; Sures I; Azam M; Brakebush C; Chieco-Bianchi L; Amadori A
Clin Exp Immunol; 1998 Sep; 113(3):394-400. PubMed ID: 9737668
[TBL] [Abstract][Full Text] [Related]
31. Mac-2 binding protein is a cell-adhesive protein of the extracellular matrix which self-assembles into ring-like structures and binds beta1 integrins, collagens and fibronectin.
Sasaki T; Brakebusch C; Engel J; Timpl R
EMBO J; 1998 Mar; 17(6):1606-13. PubMed ID: 9501082
[TBL] [Abstract][Full Text] [Related]
32. CD6 recognizes the neural adhesion molecule BEN.
Skonier JE; Bowen MA; Aruffo A; Bajorath J
Protein Sci; 1997 Aug; 6(8):1768-70. PubMed ID: 9260290
[TBL] [Abstract][Full Text] [Related]
33. Role of the CD6 glycoprotein in antigen-specific and autoreactive responses of cloned human T lymphocytes.
Singer NG; Richardson BC; Powers D; Hooper F; Lialios F; Endres J; Bott CM; Fox DA
Immunology; 1996 Aug; 88(4):537-43. PubMed ID: 8881754
[TBL] [Abstract][Full Text] [Related]
34. Molecular linkage of the mouse CD5 and CD6 genes.
Lecomte O; Bock JB; Birren BW; Vollrath D; Parnes JR
Immunogenetics; 1996; 44(5):385-90. PubMed ID: 8781125
[No Abstract] [Full Text] [Related]
35. Differentiation between MHC-restricted and non-MHC-restricted porcine cytolytic T lymphocytes.
Pauly T; Weiland E; Hirt W; Dreyer-Bux C; Maurer S; Summerfield A; Saalmüller A
Immunology; 1996 Jun; 88(2):238-46. PubMed ID: 8690456
[TBL] [Abstract][Full Text] [Related]
36. Molecular model of the N-terminal receptor-binding domain of the human CD6 ligand ALCAM.
Bajorath J; Bowen MA; Aruffo A
Protein Sci; 1995 Aug; 4(8):1644-7. PubMed ID: 8520490
[TBL] [Abstract][Full Text] [Related]
37. Cloning and characterization of cyclophilin C-associated protein: a candidate natural cellular ligand for cyclophilin C.
Friedman J; Trahey M; Weissman I
Proc Natl Acad Sci U S A; 1993 Jul; 90(14):6815-9. PubMed ID: 8341703
[TBL] [Abstract][Full Text] [Related]
38. Cloning, mapping, and characterization of activated leukocyte-cell adhesion molecule (ALCAM), a CD6 ligand.
Bowen MA; Patel DD; Li X; Modrell B; Malacko AR; Wang WC; Marquardt H; Neubauer M; Pesando JM; Francke U
J Exp Med; 1995 Jun; 181(6):2213-20. PubMed ID: 7760007
[TBL] [Abstract][Full Text] [Related]
39. Tyrosine phosphorylation of CD6 by stimulation of CD3: augmentation by the CD4 and CD2 coreceptors.
Wee S; Schieven GL; Kirihara JM; Tsu TT; Ledbetter JA; Aruffo A
J Exp Med; 1993 Jan; 177(1):219-23. PubMed ID: 7678115
[TBL] [Abstract][Full Text] [Related]
40. Bovine gall-bladder mucin contains two distinct tandem repeating sequences: evidence for scavenger receptor cysteine-rich repeats.
Nunes DP; Keates AC; Afdhal NH; Offner GD
Biochem J; 1995 Aug; 310 ( Pt 1)(Pt 1):41-8. PubMed ID: 7646470
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
